In an effort to delineate the identity of other proteins which are SUMOylated in GBM we performed global SUMO-1 IPs and subjected those proteins that were pulled-down to liquid chromatography (LC)/mass spectrometry (MS)/MS analysis. Here, SUMO1 is linked to glioblastoma.